FACT CHECK: FOX43 Deems Casey Campaign Ad On Fentanyl ‘True’, While McCormick Attack Ad Is ‘False’
FOX43: “We Can Verify, the Statement [Casey] Personally Owns the [Humanwell] Stock Is False.”
FOX43: “Casey Released an Ad Early This Month […] “McCormick Invested Millions in China’s Biggest Fentanyl Producer.” […] This Claim Is True.”
PENNSYLVANIA – A new fact check from FOX43 calls out David McCormick’s lie and confirms that Senator Casey did not invest in China’s largest fentanyl — unlike David McCormick. Additionally, FOX43 rated the Casey campaign’s ad exposing McCormick’s fentanyl investments as true.
While CEO of Bridgewater Associates, McCormick invested $1.7 million in a Chinese fentanyl manufacturer at a time when thousands of Pennsylvanians died from fentanyl overdoses.
FOX43: Verifying Casey, McCormick claims of Chinese fentanyl investment
- Democratic Senator Bob Casey released an ad early this month, taking aim at Republican Senate Nominee Dave McCormick’s time as CEO of Bridgewater Associates.
- “As CEO of Wall Street’s largest hedge fund, McCormick invested millions in China’s biggest fentanyl producer.”
- Bridgewater Associates’ tax filings with the IRS and Department of Labor show that seven of the company’s hedge funds invested a total of close to $1.7 million in Humanwell Healthcare in 2021, while McCormick was CEO.
- McCormick told the American Enterprise last year, “I was the CEO, so whatever we did I’m responsible for.”
- So, this claim is true.
- This week, McCormick released another ad.
- Senator Casey’s personal financial disclosures include a 529 savings plan with $15,000 -$50,000 invested in a Massachusetts College mutual fund, whose investment strategies Casey does not have control over.
- That fund is partially invested in an index fund called Fidelity Series Global, 0.001% of which is Humanwell Healthcare stock.
- That means Casey’s investment is valued at between 1/8th of a cent and three cents.
- So […] we can Verify, the statement he personally owns the stock is false.
###